Shaloo Pandhi

Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study

Shuu‐Jiun Wang, Artemio Roxas, B. Saravia et al. · Cephalalgia · 2021 · 65 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathy

Andrew S.C. Rice, Robert H. Dworkin, Nanna Brix Finnerup et al. · Pain · 2021 · 50 citations

Medicine, Neurology, Pharmacology +17

Two-year efficacy and safety of erenumab in participants with episodic migraine and 2–4 prior preventive treatment failures: results from the LIBERTY study

Michel Dominique Ferrari, Uwe Reuter, Peter J. Goadsby et al. · Journal of Neurology Neurosurgery & Psychiatry · 2021 · 26 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +17

A comparison of immunogenicity and safety of indigenously developed liquid (DTwPHB-Hib) pentavalent combination vaccine (Shan 5) with Easyfive (Liq) and Tritanrix + Hiberix (Lyo) in Indian infants administered according to the EPI schedule

Raman Rao, Mandeep Singh Dhingra, Sandeep B Bavdekar et al. · Human Vaccines · 2009 · 18 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Estimands in a Chronic Pain Trial: Challenges and Opportunities

Francesca Callegari, Mouna Akacha, Peter Quarg et al. · Statistics in Biopharmaceutical Research · 2019 · 17 citations

Nursing, Pharmacotherapy, Pain Management +8